Corsair’s AI Workstation 300 (AMD Ryzen AI MAX+ 395, 96GB unified VRAM) targets the local AI market, which is growing. Q1 beat consensus, record gross margins, EBITDA raised to $110M, net income positive. The stock trades at 0.59x trailing sales while “AI” peers command 8-12x. A modest re-rate to 2.5-3x sales implies a $45 price target without heroic revenue assumptions. Analysts (Barclays $11) have not updated the narrative. Long CRSR as a value play with an AI catalyst. The thesis is credible but execution risk exists; entry near $11 after a 30% gap-up reduces margin of safety. EagleTree overhang, AMD chip availability/execution, macro slowdown, component shortages, potential misjudgment of AI demand.
Corsair’s AI Workstation 300 (AMD Ryzen AI MAX+ 395, 96GB unified VRAM) targets the local AI market, which is growing. Q1 beat consensus, record gross margins, EBITDA raised to $110M, net income positive. The stock trades at 0.59x trailing sales while “AI” peers command 8-12x. A modest re-rate to 2.5-3x sales implies a $45 price target without heroic revenue assumptions. Analysts (Barclays $11) have not updated the narrative. Long CRSR as a value play with an AI catalyst. The thesis is credible but execution risk exists; entry near $11 after a 30% gap-up reduces margin of safety. EagleTree overhang, AMD chip availability/execution, macro slowdown, component shortages, potential misjudgment of AI demand.